Clinical Trials Browser

Phase 2 × Urinary Bladder Neoplasms × Panitumumab × Clear all

NCT01916109 2016-02-12

Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

Phase 2 Terminated

4 enrolled 6 charts

Cone Dystrophy 3, Urinary Bladder Neoplasms

NCT01374789 2015-06-03

PURO

Phase 2 Terminated

Urinary Bladder Neoplasms